for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Eurofins Scientific SE

EUFI.PA

Latest Trade

464.60EUR

Change

3.00(+0.65%)

Volume

18,622

Today's Range

458.60

 - 

468.00

52 Week Range

298.20

 - 

483.00

As of on the Euronext Paris ∙ Minimum 15 minute delay

Latest Developments

Eurofins Discovery Announces Founding Partner Sponsorship Agreement With BioLabs San Diego

Oct 30 (Reuters) - Eurofins Scientific SE <EUFI.PA>::EUROFINS DISCOVERY - FOUNDING PARTNER SPONSORSHIP AGREEMENT WITH BIOLABS SAN DIEGO.

Eurofins Discovery Partners With Escient Pharmaceuticals

Oct 28 (Reuters) - Eurofins Scientific SE <EUFI.PA>::EUROFINS DISCOVERY ANNOUNCES COLLABORATION WITH ESCIENT PHARMACEUTICALS.

Eurofins Q3 Revenue Up At EUR 1.2 Bln, Confirms Outlook

Oct 28 (Reuters) - Eurofins Scientific SE <EUFI.PA>::EUROFINS REPORTS STRONG ORGANIC GROWTH (OVER 6%) IN Q3 2019.Q3 2019 REVENUES INCREASED 22.3% YEAR-ON-YEAR TO EUR 1,167M VERSUS EUR 955M IN Q3 2018.WE REMAIN CONFIDENT ON OUR ABILITY TO ACHIEVE OUR OBJECTIVES FOR THIS AND NEXT YEAR.STRONG ORGANIC GROWTH OF 6.4% REPORTED IN Q3 2019.BY END OF 2020, THIS EXCEPTIONAL INVESTMENT PHASE STARTED IN 2016 WILL LARGELY BE COMPLETED.GROUP SHOULD START SIGNIFICANTLY IMPROVING CASH FLOW GENERATION AND RETURN ON INVESTMENT FROM 2021 ONWARDS.ESTIMATED IMPACT OF LOSS OF REVENUE AND PROFIT AND ADDITIONAL EXPENSES RESULTING FROM JUNE 2(ND) CYBER-ATTACK IS CONFIRMED TO BE OF SAME MAGNITUDE AS MENTIONED IN OUR HALF-YEAR REPORT.WE REMAIN CONFIDENT ON OUR ABILITY TO ACHIEVE OUR OBJECTIVES FOR THIS AND NEXT YEAR - CEO.

Eurofins Repays EUR 58.4 Million Jan 2020 Hybrid Capital Instrument Outstanding Notes

Oct 18 (Reuters) - EUROFINS SCIENTIFIC SE <EUFI.PA>::ANNOUNCED ON THURSDAY IT REPAID THE REMAINING EUR 58.4 MILLION OUTSTANDING NOTES FOR THE HYBRID CAPITAL INSTRUMENT THIS WEEK AT FACE VALUE TOGETHER WITH ACCRUED INTEREST.CONCLUDED THE REFINANCING EXERCISE OF ITS EUR 300M 7%-COUPON HYBRID CAPITAL INSTRUMENT, THANKS TO THE ISSUANCE OF A NEW EUR 300M 2.875%-COUPON HYBRID CAPITAL INSTRUMENT AS ANNOUNCED ON SEPT 4.AS A RESULT, BLENDED AVERAGE COUPON ON ITS THREE HYBRID INSTRUMENTS WILL FALL BELOW 3.7% IN 2020 .AFTER FINALISING REFINANCING EXERCISE, EUROFINS HAS NEITHER A BOND MATURITY DUE NOR A HYBRID CAPITAL CALL DATE PRIOR TO JANUARY 2022.

Eurofins Updates On Tender Offer On Its EUR 300 Mln Outstanding Hybrid Notes

Sept 11 (Reuters) - Eurofins Scientific SE <EUFI.PA>::EUROFINS ANNOUNCES THE SUCCESS OF ITS TENDER OFFER ON ITS 300M€ OUTSTANDING HYBRID NOTES WITH A FIRST CALL DATE ON 31 JANUARY 2020.SETTLEMENT OF PURCHASE IS EXPECTED TO TAKE PLACE ON 13 SEPTEMBER 2019..AT EXPIRATION DEADLINE (10 SEPTEMBER 2019, 4PM CET), COMPANY HAD RECEIVED VALID TENDERS OF EUR 241,600,000.FOLLOWING SETTLEMENT OF TENDER OFFER ON SEPT. 13 MORE THAN 75% OF INITIAL AGGREGATE PRINCIPAL AMOUNT OF EXISTING NOTES PURCHASED, CANCELLED.

Eurofins Scientific Raises EUR 300 Mln In Hybrid Bond Public Issuance

Sept 5 (Reuters) - EUROFINS SCIENTIFIC SE <EUFI.PA>::ANNOUNCED ON WEDNESDAY IT HAS SUCCESSFULLY RAISED EUR 300 MLN IN LATEST EURO HYBRID BOND PUBLIC ISSUANCE.NEW SERIES OF BONDS HAS NO SPECIFIED MATURITY.SERIES OF BONDS WILL BEAR A FIXED ANNUAL COUPON OF 2.875% FOR THE FIRST 3 YEARS, DATE UPON WHICH EUROFINS CAN ELECT TO REPAY THEM.TRANSACTION WAS WELL RECEIVED AND MORE THAN 3.5X TIMES OVER-SUBSCRIBED.THE HYBRID NOTES, WITH FIRST CALL DATE ON 31 JANUARY 2020, ARE CURRENTLY UNDER A TENDER OFFER.THE ISSUANCE IS FOR GENERAL CORPORATE PURPOSES.AVERAGE WEIGHTED COST OF EUROFINS HYBRID CAPITAL WILL BE BROUGHT BELOW 3.70%."IT ALLOWS EUROFINS TO SMOOTHLY ADDRESS THE REFINANCING OF THE EXISTING EXPENSIVE HYBRID NOTES," CEO SAYS.

Eurofins Scientific Intends To Issue New Hybrid Notes

Sept 3 (Reuters) - EUROFINS SCIENTIFIC SE <EUFI.PA>::INTENDS TO ISSUE NEW HYBRID NOTES TO REPLACE ITS 300MEUR OUTSTANDING HYBRID NOTES WITH A FIRST CALL DATE ON 31 JANUARY 2020.INTENDS TO LAUNCH A TENDER OFFER ON THOSE 2020 HYBRID NOTES.LAUNCH OF TENDER OFFER TO REPURCHASE ITS OUTSTANDING EUR 300,000,000 UNDATED DEEPLY SUBORDINATED FIXED TO VARIABLE RATE NOTES.

Eurofins Scientific Reiterates Its Long Term Objectives

Aug 29 (Reuters) - EUROFINS SCIENTIFIC SE <EUFI.PA>::WE HAVE NOT CHANGED OUR OBJECTIVES ON THE LONG TERM - CONF CALL.

Eurofins H1 reported EBITDA increases 28.9% year-on-year to EUR 371 mln

Aug 29 (Reuters) - EUROFINS SCIENTIFIC SE <EUFI.PA>::EUROFINS REPORTS ROBUST FINANCIAL PERFORMANCE IN H1 2019 DESPITE DISRUPTIONS FROM THE JUNE CYBER-ATTACK.H1 REVENUES INCREASED 24.3% YEAR-ON-YEAR TO EUR 2,168M IN H1 2019 VERSUS. EUR 1,743M IN H1 2018.H1 REPORTED EBITDA INCREASED 28.9% YEAR-ON-YEAR TO EUR 371M.LIKE ORGANIC GROWTH FOR Q2 AND H1 2019 CANNOT BE DETERMINED..H1 ADJUSTED EBITDA INCREASED 29.5% YOY TO EUR 415M, RESULTING IN A 19.1% ADJUSTED. EBITDA MARGIN, A 70BPS INCREASE YOY.NET FINANCIAL IMPACT (AFTER INSURANCE COMPENSATION) IS EXPECTED TO BE MUCH LOWER, AS BUSINESS INTERRUPTION INSURANCE COVERAGE FOR THIS CRIMINAL CYBER-ATTACK HAS BEEN CONFIRMED.EFFORTS TO DETERMINE AND AGREE ON EXACT DAMAGES WILL BE ON-GOING FOR A WHILE..FINANCIAL IMPACT FROM CYBER-ATTACK: IT IS TOO EARLY TO ASSESS TOTAL NET FINANCIAL IMPACT ON GROUP'S FULL-YEAR 2019 RESULTS.GROUP HAS RETURNED TO GOOD PERFORMANCE, IN LINE WITH ITS OBJECTIVES AND HAS A POSITIVE OUTLOOK ON REST OF YEAR.EUROFINS IS STILL IN DISCUSSIONS WITH ITS INSURERS REGARDING REIMBURSEMENT AMOUNT THAT THEY WILL PROVIDE.

Eurofins Scientific Acquires Lab Solution

July 8 (Reuters) - Eurofins Scientific SE <EUFI.PA>::ACQUIRES LAB SOLUTION, THEREBY STRENGTHENING ITS FOOTPRINT IN TEXTILE AND LEATHER INDUSTRIES.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up